Elevate

Elevate is Bowery Clinic’s injectable blend of BPC-157, Thymosin Beta-4, and GHK-Cu. It is designed for patients interested in a recovery-focused protocol that also supports collagen, connective-tissue, and skin-quality pathways. BPC-157 has been studied in preclinical tendon and soft-tissue models research, Thymosin Beta-4 has been investigated for wound-healing and regenerative signaling research, and GHK-Cu has been shown to stimulate collagen synthesis in fibroblast research. Elevate itself is a compounded combination, so the research applies to its individual components rather than the exact fixed blend.

Elevate is positioned around recovery, tissue resilience, collagen support, and the quality of connective-tissue remodeling. BPC-157 has been associated with cell migration and healing-related signaling in tendon models study, while Thymosin Beta-4 plays a role in cell migration and angiogenesis and has been studied in dermal repair review. GHK-Cu is a naturally occurring copper-binding peptide that participates in collagen and extracellular-matrix biology study. The goal is improved recovery capacity rather than a rapid cosmetic or performance effect.

Elevate can be appropriate for selected patients when prescribed and monitored by a clinician, but it should not be treated as risk-free. Because it is an injectable multi-peptide formula, Bowery Clinic reviews the patient’s medical history, current medications, other peptide use, and treatment goals before deciding whether the blend fits. Possible issues can include injection-site redness, tenderness, bruising, or swelling, along with ingredient-specific reactions that may be less predictable because robust human safety data are not available for every component.

Elevate is generally evaluated over 4–6 weeks. Some patients may notice improved recovery or less post-activity soreness within 1–2 weeks, while tissue-quality and collagen-related goals develop more gradually. Progress should be judged across the full treatment cycle rather than after the first few injections.

Bowery Clinic peptides are higher-strength and clinically dosed compared to most research facilities that use much lower concentrations. They are compounded by licensed 503A pharmacies with physician oversight and sterile quality standards, prioritizing real therapeutic outcomes over cheaper, unregulated research-grade products.

Yes. All pharmacies in our network are fully licensed in the states where they operate and comply with all state board of pharmacy regulations. Unlike many peptide clinics, we partner exclusively with FDA-registered U.S. pharmacies that undergo rigorous evaluation and compliance checks.

Every patient receives treatment plans developed and monitored by licensed providers. This includes safe titration of dosages and ongoing medical oversight tailored to individual needs.

Injections deliver the medication directly into your system. This makes the absorption more consistent and effective. Troches are small dissolvable lozenges that sit in your mouth until they melt, slowly releasing medication through the lining of your cheek or under your tongue.